Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

249 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Preventing Severe COVID-19 with Tixagevimab-Cilgavimab in Hematological Patients Treated with Anti-CD20 Monoclonal Antibodies: An International Multicenter Study.
Azuly H, Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, Oster Y, Zahran S, Horwitz E, Horowitz NA, Khatib H, Batista MV, Cortez AC, Brosh-Nissimov T, Segman Y, Ishay L, Cohen R, Atamna A, Spallone A, Chemaly RF, Ramos JC, Chowers M, Rogozin E, Oren NC, Keske Ş, Barchad OW, Nesher L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Azuly H, et al. Among authors: chemaly rf. Infect Dis Ther. 2024 Dec 9. doi: 10.1007/s40121-024-01089-9. Online ahead of print. Infect Dis Ther. 2024. PMID: 39652286
An international multicenter study comparing COVID-19 omicron outcomes in patients with hematological malignancies treated with obinutuzumab versus rituximab.
Shafat T, Grupel D, Porges T, Abuhasira R, Belkin A, Deri O, Oster Y, Zahran S, Horwitz E, Horowitz NA, Khatib H, Batista MV, Cortez AC, Brosh-Nissimov T, Segman Y, Ishay L, Cohen R, Atamna A, Spallone A, Chemaly RF, Ramos-Ramos JC, Chowers M, Rogozin E, Oren NC, Keske Ş, Barchad OW, Nesher L; European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Study Group for Respiratory Viruses (ESGREV). Shafat T, et al. Among authors: chemaly rf. Cancer Med. 2024 Feb;13(3):e6997. doi: 10.1002/cam4.6997. Cancer Med. 2024. PMID: 38400683 Free PMC article.
Rapid whole genome characterization of antimicrobial-resistant pathogens using long-read sequencing to identify potential healthcare transmission.
Wu CT, Shropshire WC, Bhatti MM, Cantu S, Glover IK, Anand SS, Liu X, Kalia A, Treangen TJ, Chemaly RF, Spallone A, Shelburne S. Wu CT, et al. Among authors: chemaly rf. Infect Control Hosp Epidemiol. 2024 Dec 27:1-7. doi: 10.1017/ice.2024.202. Online ahead of print. Infect Control Hosp Epidemiol. 2024. PMID: 39727230
Lethal Disseminated Mucorales Infection With Positive Blood Cultures With Purpura Fulminans Complicating Hemophagocytic Lymphohistiocytosis After Chimeric Antigen Receptor T-Cell Therapy.
Matsuo T, Wurster S, Ivan D, Hicklen R, McConn K, Bagwell KA, Khawaja F, Chemaly RF, Kontoyiannis DP. Matsuo T, et al. Among authors: chemaly rf. Open Forum Infect Dis. 2024 Oct 29;11(11):ofae647. doi: 10.1093/ofid/ofae647. eCollection 2024 Nov. Open Forum Infect Dis. 2024. Retraction in: Open Forum Infect Dis. 2024 Dec 17;11(12):ofae730. doi: 10.1093/ofid/ofae730 PMID: 39507882 Free PMC article. Retracted.
Rapid Whole Genome Characterization of High-Risk Pathogens Using Long-Read Sequencing to Identify Potential Healthcare Transmission.
Wu CT, Shropshire WC, Bhatti MM, Cantu S, Glover IK, Anand SS, Liu X, Kalia A, Treangen TJ, Chemaly RF, Spallone A, Shelburne S. Wu CT, et al. Among authors: chemaly rf. medRxiv [Preprint]. 2024 Aug 20:2024.08.19.24312266. doi: 10.1101/2024.08.19.24312266. medRxiv. 2024. Update in: Infect Control Hosp Epidemiol. 2024 Dec 27:1-7. doi: 10.1017/ice.2024.202 PMID: 39228727 Free PMC article. Updated. Preprint.
Humoral Immunity and Antibody Responses against Diphtheria, Tetanus, and Pneumococcus after Immune Effector Cell Therapies: A Prospective Study.
Angelidakis G, Chemaly RF, Sahasrabhojane PV, Morado-Aramburo O, Jiang Y, Bhatti MM, Shpall E, Hosing C, Jain P, Mahadeo KM, Khawaja F, Elhajj P, Wargo JA, Jenq RR, Ajami NJ, Kebriaei P, Ariza-Heredia EJ. Angelidakis G, et al. Among authors: chemaly rf. Vaccines (Basel). 2024 Sep 19;12(9):1070. doi: 10.3390/vaccines12091070. Vaccines (Basel). 2024. PMID: 39340100 Free PMC article.
International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Survivorship.
Raad I, Hachem R, Masayuki N, Datoguia T, Dagher H, Jiang Y, Subbiah V, Siddiqui B, Bayle A, Somer R, Cruz AF, Gorak E, Bhinder A, Mori N, Hamerschlak N, Shelanski S, Dragivich T, Kiat YEV, Fakhreddine S, Hanna PA, Chemaly RF, Mulanovich V, Adachi J, Borjan J, Khawaja F, Granwehr B, John T, Guevara EY, Torres H, Ammakkanavar NR, Yibirin M, Reyes-Gibby CC, Pande M, Ali N, Rojo RD, Ali SM, Deeba RE, Chaftari P, Matsuo T, Ishikawa K, Hasegawa R, Aguado-Noya R, García-García Á, Puchol CT, Lee DG, Slavin M, Teh B, Arias CA; Data-Driven Determinants for COVID-19 Oncology Discovery Effort (D3CODE) Team; Kontoyiannis DP, Malek AE, Chaftari AM. Raad I, et al. Among authors: chemaly rf. medRxiv [Preprint]. 2022 Aug 26:2022.08.25.22279181. doi: 10.1101/2022.08.25.22279181. medRxiv. 2022. Update in: Elife. 2023 Jan 30;12:e81127. doi: 10.7554/eLife.81127 PMID: 36097568 Free PMC article. Updated. Preprint.
249 results